Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
10.01. | SANUWAVE Health, Inc. - 8-K, Current Report | - | SEC Filings | ||
03.12.24 | SANUWAVE Health, Inc. - S-1, General form for registration of securities | - | SEC Filings | ||
08.11.24 | SANUWAVE Health reports Q3 results | 1 | Seeking Alpha | ||
08.11.24 | SANUWAVE Health, Inc.: SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results | 81 | GlobeNewswire (Europe) | Q3 2024 revenues were $9.4 million, up 89% from Q3 2023. This was an all-time quarterly record for the Company. Q3 2024 gross margin was 75.5%, vs 71.5% in Q3 2023 GAAP Operating Income was $2.0 million... ► Artikel lesen | |
08.11.24 | SANUWAVE Health, Inc. - 8-K, Current Report | - | SEC Filings | ||
07.11.24 | SANUWAVE Health, Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
25.10.24 | SANUWAVE Health, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
18.10.24 | SANUWAVE Health, Inc. - S-8, Securities to be offered to employees in employee benefit plans | 1 | SEC Filings | ||
SANUWAVE HEALTH Aktie jetzt für 0€ handeln | |||||
18.10.24 | SANUWAVE announces 1-for-375 reverse stock split | 1 | Seeking Alpha | ||
18.10.24 | SANUWAVE Health, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
18.10.24 | SANUWAVE Health, Inc.: SANUWAVE Announces Reverse Stock Split, Note and Warrant Exchange, and PIPE Offering | 96 | GlobeNewswire (Europe) | 1-for-375 reverse stock split effective at market open today Exchanged $43.2 million in principal amount of convertible notes and warrants previously exercisable for approximately 1.7 billion pre-split... ► Artikel lesen | |
16.10.24 | SANUWAVE Health Announces 1-For-375 Reverse Stock Split, Effective Oct. 18 | - | RTTNews | ||
16.10.24 | SANUWAVE Health to execute 1-for-375 reverse stock split | 2 | Seeking Alpha | ||
16.10.24 | SANUWAVE Health, Inc.: SANUWAVE Health Announces 1-For-375 Reverse Stock Split | 121 | GlobeNewswire (Europe) | Common Stock Will Begin Trading on a Split-adjusted Basis on October 18, 2024 EDEN PRAIRIE, Minn., Oct. 16, 2024 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (the "Company" or "SANUWAVE") (OTCQB: SNWV)... ► Artikel lesen | |
13.08.24 | SANUWAVE Health reports Q2 results | 1 | Seeking Alpha | ||
13.08.24 | SANUWAVE Health, Inc.: SANUWAVE Announces Record Quarterly Revenues: Q2 FY2024 Financial Results | 102 | GlobeNewswire (Europe) | Q2 2024 revenues were $7.2 million, up 53% from Q2 2023. This was an all-time quarterly record for the Company. Q2 2024 Gross Margin was 73%, vs 74% in Q2 2023 GAAP Operating Income was $2.0... ► Artikel lesen | |
12.08.24 | SANUWAVE Health, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
09.08.24 | SANUWAVE Health, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
10.04.24 | SANUWAVE Health, Inc.: SANUWAVE Health Announces Preliminary Revenue Results for the First Quarter 2024 (Ended March 31, 2024) | 131 | GlobeNewswire (Europe) | SANUWAVE is pleased to announce preliminary revenues of $5.7 million to $5.9 million for the first quarter ended March 31, 2024. This represents the highest Q1 revenues in company history. Q1 2024... ► Artikel lesen | |
01.04.24 | SANUWAVE Health, Inc.: SANUWAVE Health Appoints Industry Veteran Peter Sorensen as Chief Financial Officer | 157 | GlobeNewswire (Europe) | Sorensen brings strong finance, forecasting, analysis, and capital markets experience as well as abilities in software, process automation, and human resources to SANUWAVE EDEN PRAIRIE, MN, April... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
FRESENIUS | 36,920 | -0,70 % | UBS stuft Fresenius SE auf 'Buy' | ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat die Einstufung für Fresenius mit einem Kursziel von 40 Euro auf "Buy" belassen. Die Bad Homburger müssten erklären, wie sie dem Gegenwind durch... ► Artikel lesen | |
SIEMENS HEALTHINEERS | 53,62 | -0,78 % | UBS stuft Siemens Healthineers auf 'Neutral' | ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat die Einstufung für Siemens Healthineers mit einem Kursziel von 53 Euro auf "Neutral" belassen. Die Bayern müssten das Risiko für ihre Jahresziele... ► Artikel lesen | |
FRESENIUS MEDICAL CARE | 47,180 | -0,86 % | UBS stuft FMC FRESENIUS MEDICAL CARE AG & CO KGAA auf 'Neutral' | ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat die Einstufung für FMC mit einem Kursziel von 39 Euro auf "Neutral" belassen. Beim Dialysekonzern gehe es vor allem um die Marge, schrieb Analyst... ► Artikel lesen | |
GERRESHEIMER | 67,40 | +1,58 % | EQS-PVR: Gerresheimer AG: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung | EQS Stimmrechtsmitteilung: Gerresheimer AG
Gerresheimer AG: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung
03.02.2025 / 16:53 CET/CEST
Veröffentlichung... ► Artikel lesen | |
CARL ZEISS MEDITEC | 57,80 | +0,09 % | UBS stuft CARL ZEISS MEDITEC AG auf 'Neutral' | ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat die Einstufung für Carl Zeiss Meditec mit einem Kursziel von 50 Euro auf "Neutral" belassen. Mit Blick auf die Jenaer bräuchte es vor allem... ► Artikel lesen | |
GENEDX | 72,02 | 0,00 % | GeneDx Announces Preliminary 2024 Financial Results | STAMFORD, Conn.--(BUSINESS WIRE)--GeneDx Holdings Corp. (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today reported preliminary financial results for... ► Artikel lesen | |
ALIGNMENT HEALTHCARE | 15,460 | 0,00 % | Alignment Healthcare Reports Third Quarter 2024 Results | Reports $692.4 million in total revenue, up 51.6% year-over-year Increases Medicare Advantage membership, up 57.7% year-over-year to approximately 182,300 members, beating third-quarter and year-end... ► Artikel lesen | |
ECKERT & ZIEGLER | 55,70 | +1,74 % | EQS-News: Eckert & Ziegler SE: IT-Vorfall beeinträchtigt die Kommunikationskanäle der Eckert & Ziegler SE | EQS-News: Eckert & Ziegler SE
/ Schlagwort(e): Sonstiges
Eckert & Ziegler SE: IT-Vorfall beeinträchtigt die Kommunikationskanäle der Eckert & Ziegler SE
03.02.2025 / 13:23... ► Artikel lesen | |
ADAPTHEALTH | 10,080 | -1,51 % | AdaptHealth Corp. Announces Third Quarter 2024 Results | PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including... ► Artikel lesen | |
CASTLE BIOSCIENCES | 28,150 | -2,12 % | Castle Biosciences Announces Preliminary Unaudited Fourth Quarter and Full-Year 2024 Results | FRIENDSWOOD, Texas--(BUSINESS WIRE)--Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced certain unaudited preliminary... ► Artikel lesen | |
PROCEPT BIOROBOTICS | 71,57 | +0,38 % | PROCEPT BioRobotics Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue and Adjusted EBITDA Guidance | SAN JOSE, Calif., Oct. 28, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
PRIVIA HEALTH GROUP | 23,170 | +1,18 % | Privia Health Group, Inc.: Privia Health Reports Third Quarter 2024 Financial Results | Strong Execution Across All Business and Financial MetricsRaised Full-Year 2024 Guidance to At or Above the High End for All MetricsAnnounced New Market Entry in Indiana Achieved MSSP 2023 Shared... ► Artikel lesen | |
MEDTRONIC | 87,59 | +0,02 % | Kaum Impulse für die Medtronic plc-Aktie (87,5224 €) | Im Wertpapierhandel ist die Medtronic plc-Aktie gegenwärtig unauffällig. Der jüngste Kurs betrug 90,85 US-Dollar. Kaum verändert im Vergleich zu der Schlussnotierung vom Vortag zeigt sich derzeit der... ► Artikel lesen | |
HIMS & HERS HEALTH | 40,300 | -0,02 % | Hims & Hers Health Inc. (HIMS): Among The Stocks That Started The Year On A High | ||
BUTTERFLY NETWORK | 4,595 | 0,00 % | Butterfly Network raising $76.5 million from public offering |